Drug-metabolizing Enzymes and Oxidative Stress
Musaddique Hussain,Mobeen Fatima,Saira Shaukat,Muhammad Qasim Barkat,Taha Alqahtani,Ali M. Alqahtani,Liu Mei,Wei Shi,Ximei Wu
DOI: https://doi.org/10.1016/b978-0-323-95120-3.00010-5
2022-01-01
Abstract:Cytochrome P450 enzyme system is a clan of heme oxidases that is substantial in oxidative metabolism and activation of drugs in the liver and extrahepatic sites of the body. Compounds that are metabolized through CYP450 can fabricate reactive intermediates that can deplete oxygen at molecular level and yield reactive oxygen species (ROS). Such detrimental events taking place in the body are defied and compensated by body cells via diverse defense mechanisms. Defensive mechanisms may include the induction of free radical removers, for instance, some vitamins (C and E), bilirubin, thiols, some lipophilic scavengers such as ubiquinol and enzymes, e.g., glutathione peroxidases, superoxide dismutase, or catalases to sophisticate and embellish DNA repair mechanisms. In the circumstances, when the defense is inadequate to combat these free radicals, ROS hold the charge and oxidative stress is an obvious incident to happen. The resulting oxidative stress then bows the seeds of idiosyncratic drug toxicity by damaging the cells, proteins, and DNA. Consequently, by the study of CYP-controlled modified drug metabolism and resulting in oxidative stress, plenty of malfunctions can be prevented. Ample studies have intensified the contribution of hepatic metabolism, directing toward the complex diseases. The motive of this review is to highlight the oxidative stress due to ROS that are produced during CYP-induced drug metabolism and detoxification with antioxidant therapy. The writing will also elaborate on the unexplored aspects of this field that are yet to be considered.